ArticleNigerian medical journal : journal of the Nigeria Medical Association
Knowledge, acceptance and willingness to pay for malaria vaccine among residents of a semi-urban community in Kaduna State, North-western Nigeria.
Article in Nigerian medical journal : journal of the Nigeria Medical Association. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Public awareness and acceptance of malaria vaccine in Sub-Saharan Africa: a systematic review.BMC public health · 2025Pooled it
- Awareness, acceptability and determinants of the new malaria vaccine among caregivers of under-five children in Asaba, Nigeria: a multi-centre cross-sectional study.Malaria journal · 2026Article
- Caregivers awareness, knowledge, attitudes, and perceptions towards malaria vaccine in Kole and Kwania Districts, Northern Uganda.Malaria journal · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Malaria is a life-threatening parasitic infection associated with high morbidity and mortality in endemic regions. The World Health Organization (WHO) has approved two malaria vaccines for use in children and as countries begin the phased rollout of these vaccines, uncertainties around community awareness, attitudes, and willingness to accept the vaccines remain. Methodology: This study used a multistage sampling to select 200 mostly female caregivers of children under the age of five years in Samaru, a semi-urban community in Kaduna State, North-western Nigeria. Data on knowledge, attitude, and willingness to accept the malaria vaccine was obtained using a structured questionnaire and analysed using IBM SPSS Statistics. Knowledge and attitude were scored and graded into good and poor categories. The data was presented using frequency tables and a chi-square test was used to check for associations between willingness to accept malaria vaccine and relevant variables. A Results: The majority of the respondents were females (65.5%) and married (93.0%), with a mean age of 33.1 (±9.3) years. Fifty-seven (28.5%) caregivers heard of the malaria vaccine mostly through healthcare workers and traditional media, while 39 (19.5%) showed good knowledge of the vaccine. A total of 194 (97.0%) had a good attitude towards the vaccine, 188 (94.0%) were willing to accept the vaccine, and 176 (88.0%) said they were willing to pay for it. Factors associated with vaccine acceptance included the caregiver being vaccinated as a child, having at least one child who is vaccinated, and having a good attitude toward the vaccine. Conclusion: Despite low awareness, willingness to accept the malaria vaccine was high in the community. It is recommended that immediate steps be taken by relevant stakeholders to educate the public and begin the rollout of the vaccine to avoid the spread of rumours and misconceptions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.